Home
Conditions
Bronchial Neoplasms

Clinical trial condition

Bronchial Neoplasms

Explore clinical trials studying Bronchial Neoplasms. Study availability and eligibility vary by location and protocol.

5,259 public trials 1,188 recruiting studies

Refine in advanced search Browse all conditions

Bronchial Neoplasms trial results

Not Yet Recruiting

Olomorasib + Pembrolizumab KRAS G12C Mutant, PD-L1 TPS 1-49% Locally Advanced or Metastatic NSCLC

NCT07639242

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations: University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States

View Trial Details

Not Yet Recruiting

GCC 2545- Improving Post-Radiotherapy Respiratory Function Through Sparing Serial and Parallel Components in the Lung

NCT07679607

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations: University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States

View Trial Details

Not Yet Recruiting

SYHX2011 in Combination With Carboplatin and Enlonstobart as First-Line Therapy for Squamous Non-Small Cell Lung Cancer

NCT07662811

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Management Strategy of 1L Lorlatinib With Hyperlipidemia in Stage IIIB-IV ALK Positive NSCLC

NCT07674524

Conditions: ALK Gene Mutation, ALK-positive, Bronchial Neoplasms, +16 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Not Yet Recruiting

A Study of SYS6010 Plus Anti-PD-(L)-1 Monoclonal Antibody as Adjuvant Therapy in Non-small Cell Lung Cancer (NSCLC)

NCT07672223

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Epigenomic Profiling of Circulating Cell-Free DNA (cfDNA) to Characterize the Dynamic Evolution of Molecular Subtypes in Extensive-Stage Small Cell Lung Cancer During First-Line Chemoimmunotherapy

NCT07670442

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Bright Light Therapy in Patients With Melanoma or Non-small Cell Lung Cancer (NSCLC) Who Are Receiving First-Line Immune Checkpoint Blockade

NCT07661966

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +19 more
Locations: Weill Cornell Medicine New York, United States

View Trial Details

Not Yet Recruiting

A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)

NCT07488923

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +20 more
Locations: Hackensack University Medical Center Hackensack, New Jersey, United States

NYU Langone Health New York, United States

Sarah Cannon Research Institute (SCRI) Nashville, Tennessee, United States

UT Southwestern Medical Center Dallas, Texas, United States

View Trial Details

Not Yet Recruiting

A Study to Evaluate GFH375 Versus Docetaxel in Participants With Non-Small Cell Lung Cancer With KRAS G12D Mutation

NCT07668752

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations: Shanghai Lung Cancer Center, Shanghai Key Laboratory of Thoracic Tumor Biotherapy, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China

View Trial Details

Not Yet Recruiting

A Study to Learn About the Study Medicine Called Ponsegromab in Adults With Lung Cancer-Associated Significant Weight Loss

NCT07663630

Conditions: Anorexia, Body Weight, Body Weight Changes, +18 more
Locations: Not specified

View Trial Details

Bronchial Neoplasms

Bronchial Neoplasms trial results

Related conditions